BARCLAYS PLC - VTV THERAPEUTICS INC ownership

VTV THERAPEUTICS INC's ticker is VTVT and the CUSIP is 918385105. A total of 23 filers reported holding VTV THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VTV THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,000
-71.4%
1,527
-52.7%
0.00%
Q2 2021$7,000
-75.0%
3,225
-67.4%
0.00%
Q1 2021$28,000
+300.0%
9,905
+178.2%
0.00%
Q4 2020$7,000
-22.2%
3,561
-23.2%
0.00%
Q3 2020$9,000
-25.0%
4,636
-11.3%
0.00%
Q2 2020$12,000
+300.0%
5,229
+219.8%
0.00%
Q1 2020$3,000
-98.6%
1,635
-98.7%
0.00%
Q4 2019$217,000
+3000.0%
127,559
+2648.5%
0.00%
Q2 2019$7,000
-85.4%
4,641
-83.4%
0.00%
Q1 2019$48,000
-35.1%
28,0000.0%0.00%
Q4 2018$74,000
+1380.0%
28,000
+366.7%
0.00%
Q3 2018$5,000
-78.3%
6,000
-59.8%
0.00%
Q2 2018$23,000
+187.5%
14,938
+617.1%
0.00%
Q1 2018$8,000
-38.5%
2,083
+1.0%
0.00%
Q4 2017$13,000
+333.3%
2,063
+328.0%
0.00%
Q3 2017$3,000
-40.0%
482
-47.8%
0.00%
Q2 2017$5,000
+400.0%
924
+477.5%
0.00%
Q1 2017$1,000
-50.0%
160
-65.7%
0.00%
Q4 2016$2,000467
+853.1%
0.00%
Q3 2016$0490.00%
Other shareholders
VTV THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 300,000$1,491,0000.25%
SABBY MANAGEMENT, LLC 117,400$583,0000.04%
ESSEX INVESTMENT MANAGEMENT CO LLC 39,779$198,0000.03%
Candriam S.C.A. 140,000$696,0000.01%
Alyeska Investment Group, L.P. 204,523$1,016,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 11,396$57,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$373,0000.00%
FRANKLIN RESOURCES INC 899,100$4,469,0000.00%
AMERIPRISE FINANCIAL INC 264,214$1,313,0000.00%
SG Americas Securities, LLC 12,845$64,0000.00%
View complete list of VTV THERAPEUTICS INC shareholders